Thakkar J K, Raju M S, Kennington A S, Foil B, Caro J F
Department of Medicine, School of Medicine, East Carolina University, Greenville, North Carolina 27858-4354.
J Biol Chem. 1990 Apr 5;265(10):5475-81.
A class of inositol phosphate-containing oligosaccharides (IPG) derived from a membrane glycan-phosphatidylinositol precursor (GPI) has been identified as a possible mediator of insulin action. Saltiel's laboratory has recently communicated an in vitro assay for the synthesis of GPI in rat liver microsomes. Herein we have established this method in rat and human liver microsomes, it being our end point to evaluate if the pool of GPI was normal in diabetes and if failure of insulin to generate IPG from GPI could be involved in the mechanism of insulin resistance in Type II diabetes. However, subsequent to the detailed study of [3H]myoinositol incorporation into phospholipids in liver microsomes from our study subjects, we demonstrated by gas chromatography/mass spectrometry analysis that the material reported to be GPI is a mixture of lysophospholipids that does not contain hexosamine, ethanolamine, or amino acids.
一类源自膜聚糖 - 磷脂酰肌醇前体(GPI)的含肌醇磷酸寡糖(IPG)已被确定为胰岛素作用的一种可能介质。萨尔蒂尔实验室最近公布了一种在大鼠肝微粒体中合成GPI的体外测定方法。在此,我们已在大鼠和人肝微粒体中建立了该方法,我们的终点是评估糖尿病患者中GPI池是否正常,以及胰岛素无法从GPI生成IPG是否可能参与II型糖尿病胰岛素抵抗的机制。然而,在对我们研究对象肝微粒体中[3H]肌醇掺入磷脂进行详细研究之后,我们通过气相色谱/质谱分析证明,据报道为GPI的物质是不包含己糖胺、乙醇胺或氨基酸的溶血磷脂混合物。